Regulation of neurokinin-1 receptor expression by GABA(B) receptor agonists

Life Sciences

Volumn 62, Issue 17-18, 1998, Pages 1525-1530

  Enna, S J ^a   Harstad, Eric B ^a   McCarson, Kenneth E ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Gamma aminobutyric acid; Nociception; Spinal cord; Tachykinin; Tolerance

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; CGP 44532; NEUROKININ 1 RECEPTOR; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; CHRONIC PAIN; CONFERENCE PAPER; DRUG POTENCY; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SEDATION; SPINAL CORD;

ANIMALS; BACLOFEN; GABA AGONISTS; GENE EXPRESSION REGULATION; MALE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SPINAL CORD;

EID: 0032571353     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00101-5     Document Type: Conference Paper

References (19)

1. 1. S. ARAN and D.L. HAMMOND, J. Pharmacol. and Exp. Therap. 257 360-368 (1991)
2. 2. R.P. BARBER, J.E. VAUGHN, J.R. SLEMMON, P.M. SAVATERRA, E. ROBERTS, and S.E. LEEMAN, J. Comp. Neurol. 184 331-352 (1979).
3. 3. M.D. CUNNINGHAM and S.J. ENNA, Brain Res. 720 220-224 (1996).
4. 4. Y. DeKONINCK, A. RIBERIO-da-SILVA, J.L. HENRY, and C. CUELLO, Proc. Natl. Acad. Sci. USA 89 5073-5077 (1992).
5. 5. D.M. DIRIG and T.L. YAKSH, J. Pharmacol. and Exp. Therap. 275 219-227 (1995).
6. 6. W. FROESTL, S.J. MICKEL, R.G. HALL, G. VON SPRECHER, D. STRUB, P.A. BAUMANN, F. BRUGGER, C. GENTSCH, J. JAEKEL, H.R. OLPE, G. RIHS, A. VASSOUT, P.C. WALDMEIER, and H. BITTIGER, J. Med. Chem. 38 3297-3312 (1995).
7. 7. A.D. HERSHEY and J.E. KRAUSE J.E., Science 247 958-962 (1990).
8. 8. K. KAUPMANN, K. HUGGEL, J. HEID, P.J. FLOR, S. BISCHOFF, S.J. MICKEL, G. MCMASTER, C. ANGST, H. BITTIGER, W. FROESTL, and B. BETTLER, Nature (Lond.) 386 239-246 (1997).
9. 9. D.A. KENDALL, M. BROWNER, and S.J. ENNA, J. Pharmacol. and Exp. Therap. 220 482-487 (1982).
10. 10. R.A. LEVY and H.K. PROUDFIT, J. Pharmacol. and Exp. Therap. 202 437-445 (1977).
11. 11. M. MALCAGNIO and N.G. BOWERY, J. Pharmacol. and Exp. Therap. 266 1490-1496 (1993).
12. 12. P.W. MANTYH, T. GATES, C.R. MANTYH, and J.E. MAGGIO, J. Neurosci. 9 258-279 (1989).
13. 13. K.E. McCARSON and S.J. ENNA, Pharmacol. Rev. Comm. 8 191-194 (1996).
14. 14. K.E. McCARSON and J.E. KRAUSE, J. Neurosci. 14 712-720 (1994).
15. 15. K.E. McCARSON and J.E. KRAUSE, Neurosci. 64 729-739 (1995).
16. 16. V. RADHAKRISHNAN and J.L. HENRY, Neurosci. Lett. 132 39-43 (1991).
17. 17. P. SANTICIOLI, E. DEL-BIANCO, M. TRAMONTANA, and C.A. MAGGI, Neurosci. Lett., 144 211-214 (1992).
18. 18. H. TEOH, M. MALCAGNIO, and N.G. BOWERY, British J. Pharmacol., 118 1153-1160 (1996).
19. 19. J.L. VAUGHT, K. PELLEY, L.G. COSTA, P. SETLER, and S.J. ENNA, Neuropharmacol. 24 211-216 (1985).